Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DA, Macmillan RD, Patnick J, Pinder SE.

Eur J Cancer. 2013 Jul;49(10):2294-302. doi: 10.1016/j.ejca.2013.02.031. Epub 2013 Mar 21.

PMID:
23523089
2.

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.

Johnston SJ, Kenny FS, Syed BM, Robertson JF, Pinder SE, Winterbottom L, Ellis IO, Blamey RW, Cheung KL.

Ann Oncol. 2012 Sep;23(9):2296-300. doi: 10.1093/annonc/mdr630. Epub 2012 Feb 21.

PMID:
22357257
3.

A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.

Chakrabarti J, Kenny FS, Syed BM, Robertson JF, Blamey RW, Cheung KL.

Crit Rev Oncol Hematol. 2011 Jun;78(3):260-4. doi: 10.1016/j.critrevonc.2010.04.006. Epub 2010 May 5.

PMID:
20447833
4.

A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients.

Soria D, Garibaldi JM, Ambrogi F, Green AR, Powe D, Rakha E, Macmillan RD, Blamey RW, Ball G, Lisboa PJ, Etchells TA, Boracchi P, Biganzoli E, Ellis IO.

Comput Biol Med. 2010 Mar;40(3):318-30. doi: 10.1016/j.compbiomed.2010.01.003. Epub 2010 Jan 27.

PMID:
20106472
5.

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.

Abdel-Fatah TM, Powe DG, Agboola J, Adamowicz-Brice M, Blamey RW, Lopez-Garcia MA, Green AR, Reis-Filho JS, Ellis IO.

J Pathol. 2010 Mar;220(4):419-34. doi: 10.1002/path.2663.

PMID:
20044801
6.

Tubular carcinoma of the breast: further evidence to support its excellent prognosis.

Rakha EA, Lee AH, Evans AJ, Menon S, Assad NY, Hodi Z, Macmillan D, Blamey RW, Ellis IO.

J Clin Oncol. 2010 Jan 1;28(1):99-104. doi: 10.1200/JCO.2009.23.5051. Epub 2009 Nov 16.

PMID:
19917872
7.

ONCOPOOL - a European database for 16,944 cases of breast cancer.

Blamey RW, Hornmark-Stenstam B, Ball G, Blichert-Toft M, Cataliotti L, Fourquet A, Gee J, Holli K, Jakesz R, Kerin M, Mansel R, Nicholson R, Pienkowski T, Pinder S, Sundquist M, van de Vijver M, Ellis I.

Eur J Cancer. 2010 Jan;46(1):56-71. doi: 10.1016/j.ejca.2009.09.009. Erratum in: Eur J Cancer. 2010 Jun;46(9):1762.

PMID:
19811907
8.

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.

Rakha EA, Aleskandarany M, El-Sayed ME, Blamey RW, Elston CW, Ellis IO, Lee AH.

Eur J Cancer. 2009 Jul;45(10):1780-7. doi: 10.1016/j.ejca.2009.02.014. Epub 2009 Mar 14.

PMID:
19286369
9.

Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.

Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, Blamey RW, Ellis IO.

J Clin Oncol. 2008 Jul 1;26(19):3153-8. doi: 10.1200/JCO.2007.15.5986. Epub 2008 May 19.

PMID:
18490649
10.

The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology.

Rakha EA, Gill MS, El-Sayed ME, Khan MM, Hodi Z, Blamey RW, Evans AJ, Lee AH, Ellis IO.

Breast Cancer Res Treat. 2009 Mar;114(2):243-50. doi: 10.1007/s10549-008-0007-4. Epub 2008 Apr 11.

PMID:
18404368
11.

Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgery.

Rampaul RS, Dale OT, Mitchell M, Blamey RW, Macmillan RD, Robertson JF, Ellis IO.

Breast. 2008 Apr;17(2):195-8. doi: 10.1016/j.breast.2007.09.004. Epub 2008 Mar 4.

PMID:
18164619
12.

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.

Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR, Haybittle JL, Elston CW.

Eur J Cancer. 2007 Jul;43(10):1548-55. Epub 2007 Feb 26.

PMID:
17321736
13.

Reading the prognosis of the individual with breast cancer.

Blamey RW, Pinder SE, Ball GR, Ellis IO, Elston CW, Mitchell MJ, Haybittle JL.

Eur J Cancer. 2007 Jul;43(10):1545-7. Epub 2007 Feb 22.

PMID:
17320376
14.

Guidelines on the standards for the training of specialised health professionals dealing with breast cancer.

Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, Redmond K, Rosselli Del Turco M, Rijken H, Kearney N, Ellis IO, Di Leo A, Orecchia R, Noel A, Andersson M, Audretsch W, Bjurstam N, Blamey RW, Blichert-Toft M, Bosmans H, Burch A, Bussolati G, Christiaens MR, Colleoni M, Cserni G, Cufer T, Cush S, Damilakis J, Drijkoningen M, Ellis P, Foubert J, Gambaccini M, Gentile E, Guedea F, Hendriks J, Jakesz R, Jassem J, Jereczek-Fossa BA, Laird O, Lartigau E, Mattheiem W, O'higgins N, Pennery E, Rainsbury D, Rutgers E, Smola M, Van Limbergen E, von Smitten K, Wells C, Wilson R; EUSOMA.

Eur J Cancer. 2007 Mar;43(4):660-75. Epub 2007 Feb 5.

PMID:
17276672
15.

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO.

Eur J Cancer. 2006 Dec;42(18):3149-56. Epub 2006 Oct 19.

PMID:
17055256
16.

EUSOMA accreditation of breast units.

Blamey RW, Cataliotti L.

Eur J Cancer. 2006 Jul;42(10):1331-7. Epub 2006 Jun 12.

PMID:
16766180
17.

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.

Lee AH, Pinder SE, Macmillan RD, Mitchell M, Ellis IO, Elston CW, Blamey RW.

Eur J Cancer. 2006 Feb;42(3):357-62. Epub 2005 Dec 27.

PMID:
16377180
18.

Selective use of post-mastectomy flap irradiation in high-risk breast cancer patients.

Asgeirsson KS, Holroyd B, Morgan DA, Robertson JF, Blamey RW, Pinder SE, Macmillan RD.

Breast. 2005 Aug;14(4):298-303. Epub 2005 Apr 18.

PMID:
16085236
19.
20.

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell JA, Rampaul RS, Blamey RW, Robertson JF, Nicholson RI, Ellis IO.

Br J Cancer. 2004 Oct 18;91(8):1532-42.

21.

Woman feels breast lump--surgeon cannot: the role of ultrasound in arbitration.

Cid JA, Rampaul RS, Ellis IO, Wilson AR, Burrell HC, Evans AJ, Blamey RW, Macmillan RD.

Eur J Cancer. 2004 Sep;40(14):2053-5.

PMID:
15341978
22.

Expression of luminal and basal cytokeratins in human breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO.

J Pathol. 2004 Jun;203(2):661-71.

PMID:
15141381
23.

Phenotypic similarities in bilateral breast cancer.

Kollias J, Pinder SE, Denley HE, Ellis IO, Wencyk P, Bell JA, Elston CW, Blamey RW.

Breast Cancer Res Treat. 2004 Jun;85(3):255-61.

PMID:
15111764
24.

Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?

Rampaul RS, Pinder SE, Wencyk PM, Nicholson RI, Blamey RW, Robertson JF, Ellis IO.

Clin Cancer Res. 2004 Apr 1;10(7):2578. No abstract available.

25.

Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.

Iau PT, Marafie M, Ali A, Sng JH, Macmillan RD, Pinder S, Denley HE, Ellis IO, Wenzyck P, Scott N, Cross G, Blamey RW.

Breast Cancer Res Treat. 2004 May;85(1):81-8.

PMID:
15039599
26.
27.

Management of physiological gynaecomastia with tamoxifen.

Khan HN, Rampaul R, Blamey RW.

Breast. 2004 Feb;13(1):61-5.

PMID:
14759718
28.

Cosmetic assessment of breast-conserving surgery for primary breast cancer.

Al-Ghazal SK, Blamey RW.

Breast. 1999 Aug;8(4):162-8.

PMID:
14731434
29.

Incidence of clinically significant lymphoedema as a complication following surgery for primary operable breast cancer.

Rampaul RS, Mullinger K, Macmillan RD, Cid J, Holmes S, Morgan DA, Blamey RW.

Eur J Cancer. 2003 Oct;39(15):2165-7.

PMID:
14522373
30.

Endocrine treatment of physiological gynaecomastia.

Khan HN, Blamey RW.

BMJ. 2003 Aug 9;327(7410):301-2. No abstract available.

31.
32.

Management of primary breast cancer in the elderly patient.

Blamey RW.

Eur J Cancer. 2003 Feb;39(3):286. No abstract available.

PMID:
12565978
33.

Estimation of prognosis of the individual with primary breast cancer and its applications.

Blamey RW.

Scand J Surg. 2002;91(3):273-8. Review. No abstract available.

PMID:
12449471
34.

Postoperative radiotherapy following mastectomy for high-risk breast cancer. A randomised trial.

Morgan DA, Berridge J, Blamey RW.

Eur J Cancer. 2002 May;38(8):1107-10.

PMID:
12008199
35.

Guidelines on endocrine therapy of breast cancer EUSOMA.

Blamey RW; EUSOMA.

Eur J Cancer. 2002 Mar;38(5):615-34. No abstract available.

PMID:
11916542
36.

Neuroendocrine differentiation and prognosis in breast adenocarcinoma.

Miremadi A, Pinder SE, Lee AH, Bell JA, Paish EC, Wencyk P, Elston CW, Nicholson RI, Blamey RW, Robertson JF, Ellis IO.

Histopathology. 2002 Mar;40(3):215-22.

PMID:
11895486
37.

E-cadherin as a prognostic indicator in primary breast cancer.

Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, Nicholson RI, Robertson JF.

Br J Cancer. 2001 Dec 14;85(12):1958-63.

38.

Sentinel node biopsy in breast cancer.

Macmillan RD, Rampaul RS, Blamey RW.

Lancet. 2001 Nov 24;358(9295):1815. No abstract available.

PMID:
11734273
39.

Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy.

Tan SM, Cheung KL, Willsher PC, Blamey RW, Chan SY, Robertson JF.

Eur J Cancer. 2001 Dec;37(18):2331-8.

PMID:
11720825
40.

Prognostic significance of synchronous and metachronous bilateral breast cancer.

Kollias J, Ellis IO, Elston CW, Blamey RW.

World J Surg. 2001 Sep;25(9):1117-24.

PMID:
11571945
41.

Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study.

Macmillan RD, Barbera D, Hadjiminas DJ, Rampaul RS, Lee AH, Pinder SE, Ellis IO, Blamey RW, Geraghty JG.

Eur J Cancer. 2001 Jun;37(9):1076-80.

PMID:
11378336
42.

Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.

Wahedna Y, Evans AJ, Pinder SE, Ellis IO, Blamey RW, Geraghty JG.

Eur J Cancer. 2001 Mar;37(4):459-62.

PMID:
11267854
43.

Selection of primary breast cancer patients for adjuvant endocrine therapy--is oestrogen receptor alone adequate?

Cheung KL, Nicholson RI, Blamey RW, Robertson JF.

Breast Cancer Res Treat. 2001 Jan;65(2):155-62.

PMID:
11261831
44.

Germ line mutations associated with breast cancer susceptibility.

Iau PT, Macmillan RD, Blamey RW.

Eur J Cancer. 2001 Feb;37(3):300-21. Review.

PMID:
11239752
45.

Loss of heterozygosity in bilateral breast cancer.

Kollias J, Man S, Marafie M, Carpenter K, Pinder S, Ellis IO, Blamey RW, Cross G, Brook JD.

Breast Cancer Res Treat. 2000 Dec;64(3):241-51.

PMID:
11200774
46.

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R; Combined Hormone Agents Trialists' Group and the European Organization for Research and Treatment of Cancer.

J Clin Oncol. 2001 Jan 15;19(2):343-53.

PMID:
11208825
47.

Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression.

Yip SS, Crew AJ, Gee JM, Hui R, Blamey RW, Robertson JF, Nicholson RI, Sutherland RL, Daly RJ.

Int J Cancer. 2000 Nov 1;88(3):363-8.

48.

The role of blood tumor marker measurement (using a biochemical index score and c-erbB2) in directing chemotherapy in metastatic breast cancer.

Cheung KL, Pinder SE, Paish C, Sadozye AH, Chan SY, Evans AJ, Blamey RW, Robertson JF.

Int J Biol Markers. 2000 Jul-Sep;15(3):203-9.

PMID:
11012094
49.
50.

ABC of breast diseases: screening for breast cancer.

Blamey RW, Wilson AR, Patnick J.

BMJ. 2000 Sep 16;321(7262):689-93. Review. No abstract available.

Supplemental Content

Loading ...
Support Center